Back
Recursion Pharmaceuticals Quote, Financials, Valuation and Earnings
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right here
Buy
62
RXRX
Recursion Pharmaceuticals
Last Price:
9.14
Seasonality Move:
67.46%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.Recursion Pharmaceuticals Price Quote
$9.14
+0.30 (+3.39%)
(Updated: May 6, 2024 at 11:40 AM ET)
Recursion Pharmaceuticals Key Stats
Buy
62
Recursion Pharmaceuticals (RXRX)
is a Buy
Day range:
$8.70 - $9.40
52-week range:
$4.92 - $16.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
41.78
P/B ratio:
4.48%
Volume:
3.9M
Avg. volume:
4.4M
1-year change:
71.32%
Market cap:
$2.1B
Revenue:
$43.9M
EPS:
$-1.57
How Much Does Recursion Pharmaceuticals Make?
-
How Much Are Recursion Pharmaceuticals's Sales Annually?
RXRX Revenues are $43.9M -
How Much Profit Does Recursion Pharmaceuticals's Make A Year?
RXRX net income is -$328.1M
Is Recursion Pharmaceuticals Growing As A Company?
-
What Is Recursion Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.22% -
What Is Recursion Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Recursion Pharmaceuticals Stock Price Performance
-
Did Recursion Pharmaceuticals Stock Go Up Last Month?
Recursion Pharmaceuticals share price went down by -1.01% last month -
Did RXRX's Share Price Rise Over The Last Year?
RXRX share price rose by 71.32% over the past 1 year
What Is Recursion Pharmaceuticals 52-Week High & Low?
-
What Is Recursion Pharmaceuticals’s 52-Week High Share Price?
Recursion Pharmaceuticals has traded as high as $16.75 over the past 52 weeks -
What Is Recursion Pharmaceuticals’s 52-Week Low Share Price?
Recursion Pharmaceuticals has traded as low as $4.92 over the past 52 weeks
Recursion Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Recursion Pharmaceuticals?
-
How Much Debt Does Recursion Pharmaceuticals Have?
Total long term debt quarterly is $1.1M -
How Much Cash Does Recursion Pharmaceuticals Have?
Cash and short term investments quarterly total is $391.6M -
What Is Recursion Pharmaceuticals’s Book Value Per Share?
Book value per share is 1.98
Is Recursion Pharmaceuticals Cash Flow Positive?
-
What Is RXRX Cash Flow From Operations?
Cash flow from operations (TTM) is -$287.8M -
What Is Recursion Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $140.1M -
What Is Recursion Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$10.2M
Recursion Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
RXRX return on invested capital is -71.52% -
What Is Recursion Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -50.01% -
What Is RXRX Return On Equity?
ROE is a measure of profitability and is -71.75%
Recursion Pharmaceuticals Earnings Date & Stock Price
-
What Is Recursion Pharmaceuticals's Stock Price Today?
A single share of RXRX can be purchased today for 8.84 -
What Is Recursion Pharmaceuticals’s Stock Symbol?
Recursion Pharmaceuticals trades on the nasdaq under the ticker symbol: RXRX -
When Is Recursion Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Recursion Pharmaceuticals is scheduled on May 9, 2024 -
When Is RXRX's next ex-dividend date?
Recursion Pharmaceuticals's next ex-dividend date is May 6, 2024 -
How To Buy Recursion Pharmaceuticals Stock?
You can buy Recursion Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Recursion Pharmaceuticals Competitors
-
Who Are Recursion Pharmaceuticals's Competitors?
Below is a list of companies who compete with Recursion Pharmaceuticals or are related in some way:
Recursion Pharmaceuticals Dividend Yield
Data Unavailable
Recursion Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 6.42% |
| Revenue: | -22.32% | -46.49% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 5 |
| Sell Recommendations: | 0 |
| Price Target: | 13.00 |
| Upside from Last Price: | 47.06% |